Vitexicarpin is primarily studied for its potential anti-cancer properties, showing activity against various tumor cell lines by inducing apoptosis and inhibiting cell proliferation. It has demonstrated inhibitory effects on the migration and invasion of cancer cells, particularly in breast and liver cancers, making it a candidate for oncology research. Additionally, vitexicarpin exhibits anti-inflammatory and neuroprotective effects, suggesting possible use in treating neurodegenerative conditions such as Alzheimer's disease. Its ability to modulate key signaling pathways like PI3K/AKT and MAPK underscores its role in cellular regulation and protection. Research also explores its potential as an anti-angiogenic agent, which could help in controlling tumor growth by limiting blood supply to malignancies. While still in preclinical stages, these applications highlight its therapeutic interest in multiple disease areas.